Irisin vs Glucagon

Head-to-head comparison of Irisin (Irisin (FNDC5 cleavage product)) and Glucagon (Glucagon) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyIrisinGlucagon
CategoryDiabetes & MetabolicDiabetes & Metabolic
Full NameIrisin (FNDC5 cleavage product)Glucagon
Molecular Weight~12.3 kDa3482.75
Half-Lifehours5-10 min
Amino Acids11229
Typical DoseNo approved human dose; research use only1 mg IM/SC for severe hypoglycemia or 3 mg intranasal
RouteIV|SCIM|SC|IN|IV
Purity≥98%≥98%
Studies Count7993
Research StatusPre-clinicalApproved

Irisin Benefits

  • glucose homeostasis
  • energy expenditure
  • brown-fat activation

Glucagon Benefits

  • rapid hypoglycemia reversal
  • raises plasma glucose
  • useful in emergency rescue

Irisin Dosing

not established|not established

Glucagon Dosing

1 mg IM/SC|3 mg intranasal

Irisin Side Effects

  • unknown
  • immunogenicity risk

Glucagon Side Effects

  • nausea
  • vomiting

Research Overview

Irisin

Irisin is widely explored in obesity and type 2 diabetes research because it connects exercise biology with metabolic adaptation. Human findings are mixed, so it remains a biomarker and preclinical lead rather than an approved therapy.

Glucagon

Clinical and emergency medicine use is well established for severe hypoglycemia, with newer stable formulations improving ease of administration.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Irisin stacks with:

FNDC5exercise hormone

Glucagon stacks with:

glucagonGlucaGenBaqsimiGvoke
AMPKexercise-mimeticenergy-metabolismtype-2-diabetesdiabetesmetabolicrescueglucose-regulation